CRBU Caribou Biosciences
- 3.825
- +0.115+3.10%
Caribou Biosciences News
Lacklustre Performance Is Driving Caribou Biosciences, Inc.'s (NASDAQ:CRBU) 27% Price Drop
Caribou Biosciences, Inc. (NASDAQ:CRBU) shareholders that were waiting for something to happen have been dealt a blow with a 27% share price drop in the last month. The recent drop has obliterated
Caribou Biosciences to Present Initial Dose Expansion Data From CB-010 ANTLER Phase 1 Trial in R/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
BERKELEY, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced two abstract
Express News | Caribou Biosciences Announces Oral Presentation on in Vivo Cas12a Chrdna Genome Editing at the 27TH Annual Meeting of the American Society of Gene and Cell Therapy (Asgct)
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a ChRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
BERKELEY, Calif., April 15, 2024 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced an abstract
Buy Rating Affirmed: Caribou Biosciences' Promising Trials and Strategic Market Positioning
Sector Update: Health Care Stocks Lean Higher Pre-Bell Friday
Health care stocks were leaning higher pre-bell Friday, with the Health Care Select Sector SPDR Fund (XLV) up 0.5% and the iShares Biotechnology ETF (IBB) flat recently. Nutex Health (NUTX) shares sli
Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday. Shares of Kura Sushi USA, Inc. (NASDAQ:KRUS) climbed 6% to $110.11 in pre-market trading foll
We're Hopeful That Caribou Biosciences (NASDAQ:CRBU) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining exploration companies often lose money for years before finding success with a new tr
Analysts Offer Insights on Healthcare Companies: 3SBio (OtherTRSBF), UnitedHealth (UNH) and Caribou Biosciences (CRBU)
Analysts Are Bullish on Top Healthcare Stocks: Paragon 28 (FNA), Caribou Biosciences (CRBU)
Caribou Biosciences Advances With FDA Clearance and New Trials
Caribou Biosciences Expands Clinical Development Of CB-010 With FDA Clearance Of IND In Lupus
-- FDA has cleared Caribou's IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 ---- Driven by encouraging initial safety
Biotech Roundtable: Who Will Bring the Next CRISPR Drug to Market?
With 65% Institutional Ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) Is a Favorite Amongst the Big Guns
HC Wainwright Adjusts Caribou Biosciences Price Target to $24 From $23, Maintains Buy Rating
Caribou Biosciences (CRBU) has an average rating of Buy and price targets ranging from $10 to $30, according to analysts polled by Capital IQ. Price: 5.4, Change: +0.18, Percent Change: +3.35
Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.
Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.
Analysts' Opinions Are Mixed on These Healthcare Stocks: Fusion Pharmaceuticals (FUSN), Caribou Biosciences (CRBU) and Neurogene (NGNE)
Express News | HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Raises Price Target to $24
Caribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry Point
11 Oversold NASDAQ Stocks To Buy Right Now
Analysis
Price Target
No Data
